Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

420 with CNW — Could Cannabis Drinks Be Better for Your Health?

As cannabis and cannabis products become more accessible thanks to a wave of drug reform that has swept through several territories, people are increasingly using marijuana as an alternative to other products. Due to recent advances in cannabis technology, specifically nano-emulsification, the market has seen an uptick in the supply of smooth, high-quality, cannabis-infused drinks.

Plenty of people are now using cannabis-infused beverages as an alternative to alcohol, with many of them preferring a calm relaxing drink that won’t leave them feeling hangover the next day. Dubbed “California sober,” exchanging alcoholic beverages for cannabis drinks is gaining popularity. Melissa Egan, 45, says alcohol used to exacerbate her perimenopause symptoms, heightening her nausea, dizziness, insomnia, night sweats, and hot flashes. Now that she drinks cannabis beverages instead, her perimenopause symptoms have become less severe, especially nausea and insomnia, and she doesn’t have to recover for a day or so after drinking.

But is cannabis actually a better alternative to alcohol? Is it better for a person’s health to indulge in cannabis rather than alcohol? According to industry experts, cannabis is indeed safer than alcohol, but that doesn’t mean that it is 100% risk free. Rebecca Jesseman, director of policy at the Canadian Center on Substance Use and Addiction (CCSA), says that it is difficult to conclusively state that cannabis is safer than alcohol because there isn’t a lot of research on cannabis. On the other hand, we have decades of research on alcohol use and how it affects the human body.

Additionally, she says, the two products are so different that comparing them is like comparing apples and oranges. Both substances present health risks and can lead to dependence if used in an unhealthy manner. Individually, the degree of safety will depend on how often you consume cannabis as well as the strains consumed and the consumption method. Fortunately, drinking is inherently safer than smoking. At the end of the day, however, alcohol is far more dangerous than cannabis, says Tim Stockwell, a scientist at the Canadian Institute for Substance Use Research.

Alcohol’s harms are much more prevalent and costly, with the Canadian Substance Use Costs and Harms Project, co-led by Stockwell, finding that alcohol causes 15 times as many deaths and hospitalizations compared to cannabis among women. Both cannabis and alcohol will leave a user physically and mentally impaired, with consuming too much cannabis in one sitting leaving you anxious and paranoid while overindulging in alcohol makes you irritable or aggressive. However, while too much alcohol can cause death via alcohol poisoning, you cannot overdose on cannabis. Stockwell concedes that more research on the effects of cannabis is needed, although several longitudinal studies of regular users haven’t revealed a major problem yet.

With the entry of companies such as BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) into the cannabis drinks space, consumers now have plenty of options to choose from.

NOTE TO INVESTORS: The latest news and updates relating to BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) are available in the company’s newsroom at http://cnw.fm/BVNNF

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — The Difference Between CBD Oil, Cannabis Oil

The popularity of CBD oil has grown in the health and wellness space, with anecdotal evidence suggesting that it can help manage depression, anxiety, stress and pain. Cannabidiol, or CBD, oil and cannabis oil have also been advertised as natural alternatives to standard prescription medications, which many believe are one and the same. While both oils are derivatives of the cannabis plant, they are inherently different. We look at some of these differences below.

What is cannabis oil?

Cannabis oil contains THC, which is the mind-altering compound that causes an individual to get high. The sale, consumption and possession of the marijuana plant is still illegal under federal law, despite being legal recreationally in 18 states and medically legal in more than 35 states. This means that under the law, the products are considered narcotics, which makes it harder and illegal to acquire them.

In other countries, however, individuals can be prescribed cannabis oil for medical applications. It is mainly used as an alternative treatment option when other treatments have proven ineffective. Experts believe that cannabis oil can help manage issues such as pain and insomnia.

Most people also consider consuming cannabis oil to be healthier than smoking the substance, with some believing the oil to be more potent. Some individuals also believe that administering a dose of oil is more accurate than smoking the substance.

What is CBD oil?

CBD oil can be made from either the marijuana plant or the hemp plant. However, most CBD products found across the country are made from hemp as it is not legal to sell CBD products made from the cannabis plant. This is because the marijuana plant contains more than 0.3% THC, which is the psychoactive component that induces a high.

The hemp plant contains many phytocannabinoids, including cannabidiol, cannabichromenic acid, cannabigerolic acid and cannabinol, among others. CBD oil is made by mixing a carrier oil with CBD extract. Most companies use hempseed oil or olive oil as carrier oils as they boost a product’s flavor and bioavailability.

CBD oil can be categorized into three forms: full spectrum, broad spectrum and isolate.

Full-spectrum CBD oil contains all the phytocannabinoids and terpenes found in hemp. These compounds are mixed together to support the entourage effect, which produces a better effect than individual components.
Broad-spectrum CBD oil contains cannabidiol and other phytocannabinoids, excluding THC.
CBD isolate, which is is 99.9% CBD oil. It is the purest type of CBD oil as it contains no terpenes or other phytocannabinoids.

Established companies such as Golden Triangle Ventures Inc. (OTC: GTVH) formulate a variety of hemp-derived CBD products geared at addressing the needs of different consumers.

NOTE TO INVESTORS: The latest news and updates relating to Golden Triangle Ventures Inc. (OTC: GTVH) are available in the company’s newsroom at https://nnw.fm/GTVH

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Why Careful Cannabis Preparation Is Crucial to High-Quality Extracts

Just a couple of years into America’s state-legal cannabis industry, extracts have eclipsed cannabis flower to become the most popular cannabis product. Last year, marijuana concentrate sales increased by 40% and accounted for a large percentage of marijuana sales. People are looking for safer, more discreet ways to consume cannabis, and consequently, smoking cannabis flower and vaping have been edged out by cannabis extracts. However, marijuana extracts are quite complex to produce, requiring precise, expert care from the time the cannabis plants are in the ground until they reach the factory.

In the early days of cannabis extraction, most cannabis extractors used whatever cannabis they could get their hands on to extract cannabinoids, regardless of the trim’s quality. However, cannabis plants absorb and store any material present in the soil, whether it is minerals and nutrients or toxic pesticides and herbicides. These impurities eventually show up in whatever product the cannabis biomass is used to make, significantly reducing their quality and making them unsafe to consume.

With that in mind, companies committed to producing high-quality cannabis extracts have to use organically grown, high-quality cannabis that has no impurities and was harvested, dried and cured properly.

Liad Chatow, the head of research and development at California-based terpene manufacturer Eybna Technologies, notes that the chances of obtaining a high-quality product depend on the richness of the raw ingredient. Less than stellar care can result in moldy cannabis, reduced potency and lost terpenes, he states, ultimately impacting the quality of the final product. Since nothing can be done to reverse this kind of damage to the raw material, extractors can save themselves significant time and money by ensuring they source organically grown cannabis that has received proper care before and after harvest.

California-based Papa & Barkley ensures the cannabis it purchases for extraction is in good shape by sending temp workers to cannabis cultivators to trim and prepare the raw cannabis to company specifications. It is the responsibility of companies to make sure that the cannabis they purchase was treated right at the farm as, unlike most industries, cannabis has no industry standards, says Papa & Barkley’s chief product officer Guy Rocourt.

On the other hand, Jason Muniz, founder and president of Texas-based hemp extractor and decorticator Texas Blue Diamond Solutions, says that proper harvesting, curing and storage before extraction is the farmers’ responsibility. His prediction is that at some point in the future, farmers will sell their hemp and cannabis at different price points depending on their quality, much like tobacco.

The highest-quality raw material would come at a premium while the lower-quality cannabis would be cheaper, he says. But before that happens, extractors who want a piece of the lucrative extracts market have to ensure the raw material they use is in good shape. This is precisely what leading companies such as The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) do in order to come up with products that customers learn to rely on.

NOTE TO INVESTORS: The latest news and updates relating to The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) are available in the company’s newsroom at http://cnw.fm/WTER

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Hero Technologies Inc. (HENC), Veteran Hemp Company Setting High Bar in Dynamic Marketplace

Hero Technologies (OTC: HENC) and its wholly owned subsidiary Veteran Hemp Company vow to hold themselves and their products to the highest of standards as the cannabis industry grows and an increasing number of companies rush to enter the space. In addition to setting a high bar of distinction in the dynamic marketplace, the subsidiary offers another unique aspect to cannabis company ownership in its founding by veterans. “Initially, this group of entrepreneurial veterans found a nook in the American cannabis industry on the security side of things. They started, grew and then sold several cannabis security companies before deciding that they wanted to focus their talents and hard-earned knowledge of cannabis businesses into a far more product-focused role,” reads a recent article discussing the company’s positioning. “We began offering our sales, marketing and business development consulting to burgeoning cannabis industries to enable our clients to expand their platform and sell more product,” the company’s story states (https://cnw.fm/TkdB4). “Eventually, we decided that our passion for improving the standard and accessibility of cannabis products needed a more direct approach. And, so, we founded Veteran Hemp Company.” To view the full article, visit https://cnw.fm/2UR68 About Hero Technologies Inc. Hero Technologies is a cannabis company working toward a vertically integrated business model. The company owns a majority stake in BlackBox Systems and Technologies LLC, an aeroponic cannabis cultivation system that provides optimal growing conditions to enhance photosynthesis and cultivation of large flowering plants, creating increased harvest efficiencies. Hero Technologies’ strategic business plan includes cannabis genetic engineering, farmland for both medical and recreational cannabis cultivation, production licenses, distribution licenses, consumer packaging, and retail and dispensary operations that make the company a multi-state operator (“MSO”). For more information about the company, visit www.HeroTechnologiesInc.com. NOTE TO INVESTORS: The latest news and updates relating to HENC are available in the company’s newsroom at https://cnw.fm/HENC About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer Do you have questions or are you interested in working with CNW? Ask our Editor CannabisNewsWire (CNW) Denver, Colorado www.CannabisNewsWire.com 303.498.7722 Office Editor@CannabisNewsWire.com CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Builds Out New Florida Facility for Edibles Production

Red White & Bloom (CSE: RWB) (OTCQX: RWBYF), a leading provider of cannabis brands in the United States, announced that it has built-out a new production facility. The facility meets GMP specifications and enables the company to capitalize on the expanding cannabis derivative market in Florida. The new 4,800-square-foot structure is located at RWBYF’s Sanderson, Florida, location and was built to meet the fast-growing demand for edibles. According to a BDSA report, the state’s medical cannabis market has been projected to reach $1.5 billion in sales in 2021, which would be a 53% increase compared to 2020 numbers; the same report noted that, with both recreational and medical cannabis expected to be legal in Florida by 2023, the market is forecast to total $2.6 billion by 2026. Red White & Bloom is working on the development of a branded capsule and rosin line along with an exclusive line of chocolates that the company anticipates will be available later this year. “We are very pleased to have completed this state of the art production facility ahead of time and begin production this month,” said Red White & Bloom general manager Jim Frazier in the press release. “We will begin with premium specialized confectionary offerings as finished retail-ready packages where medical patients will be able to select from a variety of different products. We are confident this new facility, coupled with our expert staff of edible specialists, can produce a market-leading offering.”

To view the full press release, visit https://cnw.fm/0AIsE

About Red White & Bloom Brands Inc.

Red White & Bloom Brands is positioning itself to be one of the top-three, multistate cannabis operators active in the U.S. legal cannabis and hemp sector. RWB is predominantly focusing its investments on major U.S. markets, including Michigan, Illinois, Florida, Arizona and California, with respect to cannabis, as well as the United States and internationally for hemp-based CBD products. For more information about the company, please visit www.RedWhiteBloom.com.

NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://cnw.fm/RWBYF

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Marks Milestone as First Hemp Company to Develop ESG Report Using SASB Framework

Green Hygienics (OTCQB: GRYN), an innovative, technology-driven enterprise focused on the high-standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids, has announced the publication of its first annual Environmental, Social and Governance (“ESG”) Report. The company published the report using the Sustainability Accounting Standards Board (“SASB”) framework and, according to the announcement, is the first industrial hemp company in the United States to do so. GRYN’s inaugural report validates the company’s commitment to establishing a benchmark in the industry and its focus in creating a more sustainable future in three distinct areas: economic viability, eco-responsibility and social equity. The company is collaborating with Keramida Inc., a premier environmental engineering and sustainability consulting firm, as it works to fulfill its states mission of enhancing long-term company value while promoting a more transparent path of sustainable development. In addition, Green Hygienics is working to reduce the impact of climate change, and this summer, the company became a proud member of the 1% for the Planet program, a group whose members donate 1% of future profits to nonprofit organizations that are working to resolve the planet’s most pressing environmental issues. “Our financial and operational performance and key strategic objectives are dependent on our relationships and understanding our environmental impact,” said Green Hygienics CEO Ron Loudoun in the press release. “Our ESG report will set key performance indicators and provide coherent information useful to our stakeholders.”

To view the full press release, visit https://cnw.fm/mAZwi

About Green Hygienics Holdings Inc.

Green Hygienics is focused on the hygienics, or science, of preserving and promoting the health of individuals, communities and the planet; this is the company’s core mission and is at the heart of every decision the company makes. As more and more consumers prioritize their health and demand transparency and integrity from the companies that create their products, Green Hygienics will be recognized as the most reliable, safe and secure choice in the market for CBD and hemp products. To deliver on this promise, the company maintains a constant commitment to sustainable farming practices, cutting-edge science and industry-leading certifiability. Generating peak value from a plant of this caliber requires prioritizing innovative processing methods and impeccable attention to detail. Creating a secure supply chain and reliable long-term source for high-grade CBD is a corporate strategy for Green Hygienics, coupled with a mission to preserve and protect a valuable natural resource. As Green Hygienics evolves and expands, its path is clear and uncompromised, creating pure, nonpsychoactive nutraceutical, pharmaceutical, topical and industrial products from the highly sustainable hemp plant to benefit people and preserve the planet. For more information about the company, visit www.GreenHygienics.com.

NOTE TO INVESTORS: The latest news and updates relating to GRYN are available in the company’s newsroom at http://cnw.fm/GRYN

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — The Potential Benefits of CBD Skincare Products

You have probably heard of CBD, or cannabidiol, before. Extracted from cannabis or hemp, this chemical compound is said to have a wide variety of medical applications ranging from relieving pain and anxiety to treating seizures in epileptic patients. Thanks to its supposed medical potential, CBD can now be found in myriad wellness and health products, with the skincare industry especially taking a liking to the versatile hemp extract. But just how beneficial are these CBD-infused sunscreens, lip balms, moisturizers, lotions, masks and other skincare offerings?

According to Austin Kaz, a co-founder of New York-based Sheabrand, skincare product manufacturers add CBD to their products to give those products an extra kick, making them much more effective at treating skin conditions, including acne, eczema and dry skin. One of cannabidiol’s more well-known uses is as an anti-inflammatory agent, making it a great addition to products meant to address inflammatory skin conditions such as eczema, psoriasis and dermatitis. CBD does this by interacting with the receptors in the endocannabinoid system and reducing interleukins, which are cell-signaling molecules that can stimulate inflammation.

A couple of studies have found that CBD may have the ability to nourish and rejuvenate dry skin, subsequently reducing itching. Results from a study published in the March–April issue of “Journal Clinical Therapeutics” show that CBD may be able to improve levels of skin hydration by moisturizing the skin and preventing it from losing water and boost skin elasticity. However, the researchers behind the study say this may be due to CBD’s anti-inflammatory properties or the fatty acids in the ointments the participants used, so more research with a much larger set of participants is needed.

Usually, dermatologists will prescribe topical steroidal creams, which act as anti-inflammatory agents, to treat some skin diseases. While these creams are perfectly safe and work great for most people, some individuals are not comfortable with using steroids of any kind. Robert Dellavalle, an adjunct professor of epidemiology at the Colorado School of Public Health, says that nonsteroidal therapies that use CBD can fill this gap. This type of therapy has also achieved promising results against a condition that affects millions of people from puberty well into adulthood: acne.

CBD’s anti-inflammatory properties combined with its influence on the production of sebum by skin cells via the CB2 receptors on the sebaceous glands make cannabinoid a potential therapy against acne. Additionally, research shows that topical CBD may be able to help kill gram-positive bacteria that are a known cause of acne. Finally, a CBD-infused sunscreen may help alleviate the effects of sunburns, such as redness.

However, do not look at CBD as a cure-all. Most of the evidence in its favor is anecdotal, and researchers say that even though preliminary studies have uncovered positive results, more research is needed. For the time being, do your homework on CBD, choose high-quality products and make sure you speak to your doctor before you use CBD, especially if you are pregnant or on other medication.

Companies such as Hero Technologies Inc. (OTC: HENC) focus on offering the benefits of CBD while making infused products addressing the skincare needs of their clients.

NOTE TO INVESTORS: The latest news and updates relating to Hero Technologies Inc. (OTC: HENC) are available in the company’s newsroom at https://cnw.fm/HENC

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — CBD Cosmetics Market Expected to Expand to $210 Billion by 2028

A recently published report that focused on the burgeoning CBD market estimates that by 2028, the global legal cannabis market will have reached $70.6 billion. Marijuana is one of the largest growth industries on the stock market. However, not all cannabis business segments are equal, with estimates showing that in the near future, some segments will considerably surpass others. One specific segment to watch is the CBD-infused products market.

CBD, or cannabidiol, is the nonpsychoactive compound found in the hemp and cannabis plants. It is one of the two most abundant compounds found in the cannabis plant, with the other compound being THC, which is psychoactive.

Currently, the edibles segment makes up the biggest share of the CBD-infused market. However, the cosmetics segment is expected to occupy a larger share in the near future. CBD-infused products include salves, lotions, gels and balms, which can be applied directly to the skin. These topicals are used for various symptoms, including muscle soreness, inflammation and localized pain.

You may be asking yourself if CBD-infused personal care products can really do all that.

In fact, studies have shown that CBD possesses anti-oxidant and anti-inflammatory properties, which may help deal with skin issues such as acne. Research has also found that CBD-infused topicals can be used to treat other issues, including psoriasis, dermatitis, cramping, headaches and arthritis.

Many individuals want to feel and look younger and healthy. This is why the international personal care and beauty market is valued at roughly $420 billion, with projections showing that by 2026, the market will have hit almost $560 billion. The increased adoption of these personal- care products is a main facilitator of the global CBD market’s growth. The market is expected to expand at a compound annual growth rate of 26.5%.

Forecasts show that between now and 2028, the CBD-infused product market will reach $216.7 billion, expanding at a compound annual growth rate of 45.6%. Projections also show that in the period between 2020 and 2024, the cosmetics market will expand at a compound annual growth rate of about 25%.

Canada and the United States are leading this growth, with at least 35 states in the U.S. legalizing medical cannabis, and Canada legalizing both recreational and medical marijuana. Other key markets for CBD-infused cosmetics include the United Kingdom, Mexico, China and Germany.

Various companies have joined the CBD-infused cosmetics market, including Valens Company Inc., which is involved in the sale of health as well as wellness products such as CBD bath bombs. Flora Growth Corp. (NASDAQ: FLGC) has also entered the market and offers a line of CBD wellness products.

NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom at https://cnw.fm/FLGC

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Slated for Live Webcast at VirtualInvestorConferences.com

InMed Pharmaceuticals (NASDAQ: INM), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the clinical development of cannabinol (“CBN”), will be featured at the upcoming VirtualInvestorConferences.com. InMed president and CEO is scheduled to present a real-time, interactive presentations during the two-day conference; InMed’s presentation will start at 1:30 p.m. ET on Sept. 8, 2021. During the presentation Adams will provide an overview of the company’s recent highlights as well as answer questions from potential investors in real time. Company highlights include the announcement that it has increased the yield of its proprietary IntegraSyn(TM) rare cannabinoid manufacturing approach to 5 g/L, further improving the overall economics in advance of commercial-scale production and that it has signed a nonbinding letter of intent to acquire BayMedica, a private company that specializes in the manufacture and commercialization of rare cannabinoids. In addition, as part of a phase 2 clinical trial, InMed has filed clinical trial applications in several countries. Virtual Investor Conferences (“VIC”) has developed a reputation for being a leading proprietary investor conference series; VIC events provide an interactive forum for publicly traded companies to meet and present directly with investors.

To register for the event, visit https://cnw.fm/g2Lii

To view the full press release, visit https://cnw.fm/T0KhW

About InMed Pharmaceuticals Inc.

InMed is a clinical-stage pharmaceutical company developing a pipeline of cannabinoid-based pharmaceutical drug candidates, initially focused on the therapeutic benefits of cannabinol (“CBN”) and is developing IntegraSyn to produce pharmaceutical-grade cannabinoids. The company is dedicated to delivering new therapeutic alternatives to patients who may benefit from cannabinoid-based pharmaceutical drugs. For more information, please visit www.InMedPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to INM are available in the company’s newsroom at https://cnw.fm/INM

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Trials on Marijuana-Based Treatments for Gynecological Conditions to Begin in 2022

Clinical trials to examine the effectiveness and safety of marijuana-based treatments for various gynecological conditions are expected to begin early next year. The trials will evaluate marijuana-based pharmacology products developed by Gynica, a female technology startup company based in Jerusalem.

The startup believes that the plant’s active ingredients can help ease painful gynecological conditions, including endometriosis and painful menstruation, which is also known as dysmenorrhea. Traditional treatments, such as hormone therapy, over-the-counter painkillers and surgical intervention. can be inadequate and pose their own health risks, as in the case of endometriosis.

Endometriosis is a disorder which causes tissues that normally line the uterus, known as the endometrium, to grow outside the uterus. These tissues usually become trapped inside the body and thicken, causing a build-up of adhesions and scar tissue. This results in excessive bleeding, painful intercourse and painful menstruation. In some cases, endometriosis can cause infertility.

Endometriosis has no definitive cause and no cure. It takes between 6 to 10 years for the disorder to be properly diagnosed, despite the fact that it affects every 1 in 10 women of reproductive age globally. This equates to about 180 million girls and women around the globe.

Gynica hopes to meet these unaddressed needs in women’s health by developing marijuana-based solutions for these gynecological conditions.

The CEO and co-founder of the start-up, Yotam Hod, stated that there exists so many gaps in how conditions that affect women are handled by both the scientific community and the medical community. The company has developed proprietary vaginal suppositories, which Hod says have been designed to decrease pain as well as inflammation, which is a key factor in both dysmenorrhea and endometriosis.

Dysmenorrhea is also common, with physicians noting that the associated pain varies between mild and severe. It is estimated that between 40% and 95% of women of reproductive age suffer from dysmenorrhea. Physicians note that for some individuals, dysmenorrhea and endometriosis are related.

Gynica believes that endometriosis and dysmenorrhea may be associated with a deficiency in the endocannabinoid system. The company references published research, which states that, after the brain, the female reproductive system is the region with the most endocannabinoid receptors. The endocannabinoid system is comprised of natural marijuana-like molecules produced by the human body, which regulate processes such as reproductive function, sleep, mood, appetite and pain.

Hod notes that their solutions show promise for treating these conditions and maintains that cannabinoid-based treatments may provide an improved solution for women who suffer from these conditions.

If successful, these trials could lend further credence to the profile of marijuana as a medicinal plant. The entire cannabis sector, including companies such as Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF), could benefit from the positive news such outcomes would trigger.

NOTE TO INVESTORS: The latest news and updates relating to Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) are available in the company’s newsroom at https://cnw.fm/RWBYF

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.